| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.85▼ | 6.84▲ | 6.89▼ | 6.69▲ | 6.17▲ |
| MA10 | 6.85▼ | 6.90▼ | 6.94▼ | 6.49▲ | 5.17▲ |
| MA20 | 6.86▼ | 6.95▼ | 6.84▲ | 6.12▲ | 4.62▲ |
| MA50 | 6.94▼ | 6.71▲ | 6.55▲ | 4.99▲ | 2.98▲ |
| MA100 | 6.92▼ | 6.52▲ | 6.44▲ | 4.41▲ | 2.74▲ |
| MA200 | 6.68▲ | 6.22▲ | 5.46▲ | 3.18▲ | 4.03▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | -0.035▼ | -0.024▼ | 0.016▲ | 0.238▲ |
| RSI | 44.226▼ | 49.567▼ | 55.730▲ | 73.822▲ | 77.995▲ |
| STOCH | 30.000 | 34.969 | 34.308 | 75.868 | 84.257▲ |
| WILL %R | -10.526▲ | -70.732 | -72.093 | -21.192▲ | -8.163▲ |
| CCI | 35.210 | -74.979 | -65.327 | 154.076▲ | 151.319▲ |
| CDL | $NERV Hammer Candlestick Pattern Detected | Set Alert |
|
Wednesday, March 04, 2026 04:20 AM
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates to treat CNS diseases. Minerva is initiating a confirmatory Phase 3 trial with ...
|
|
Monday, February 16, 2026 02:45 AM
Key Insights Minerva Neurosciences' significant individual investors ownership suggests that the key decisions ...
|
|
Wednesday, February 04, 2026 07:19 AM
The following slide deck was published by Minerva Neurosciences, Inc. in conjunction with this event.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/03/26 | 6.96 | 7.005 | 6.73 | 6.85 | 61,372 |
| 03/03/26 | 6.80 | 7.17 | 6.80 | 6.86 | 143,714 |
| 02/03/26 | 6.42 | 6.92 | 6.23 | 6.90 | 206,348 |
| 27/02/26 | 6.15 | 6.67 | 6.15 | 6.60 | 82,745 |
| 26/02/26 | 6.23 | 6.34 | 6.112 | 6.23 | 30,300 |
| 25/02/26 | 6.22 | 6.50 | 6.15 | 6.23 | 49,159 |
| 24/02/26 | 6.33 | 6.60 | 5.905 | 6.25 | 113,749 |
| 23/02/26 | 6.21 | 6.56 | 5.87 | 6.32 | 156,134 |
| 20/02/26 | 6.18 | 6.42 | 6.15 | 6.31 | 75,236 |
| 19/02/26 | 6.29 | 6.58 | 5.66 | 6.34 | 163,453 |
|
|
||||
|
|
||||
|
|